Chronic Obstructive Pulmonary Disease Exacerbation Clinical Trial
Official title:
National Taipei University of Nursing and Heath Sciences
The morbidity rate of Chronic Obstructive Pulmonary Disease (COPD) is increasing year by year. It is predicted to be the third leading cause of death worldwide in 2030. People with COPD have a high risk of needing a ventilator due to the decline of lung function, the increase of secretions, the dysfunction of airway clearance, and the obstruction and loss of alveolar elasticity.
This study aimed to explore the effectiveness of cough and sputum assessment and respiratory physiological indicators after training with the Bubble positive expiratory pressure (Bubble PEP) inpatients with COPD. This is a randomization control trial design survey using convenient sampling and will be to select 94 inpatients with COPD in the division of chest ward of two teaching hospital in New Taipei City. The subjects who meet the conditions for admission are explained, and they need to sign a consent form confirming that they understand the risks. More, they are randomly divided into the experimental group (experimental group n=47) and the control group (control group n=47). The experimental group receives the Bubble PEP training; the control group receives the division of chest ward routine care. The study employs a structured questionnaire including a basic demography, COPD domain, COPD assessment test (CAT), cough and sputum assessment test, and check the peak expiratory flow rate (PEFR) using it for data collection. The study needs to be approve by the Institutional Review Board. The two groups agreed to participate in the study, after completing the subject consent form before the intervention, they also received the pre-test as a benchmark for the intervention effect. After completing the 7-day and 30-day intervention, the post-test was performed immediately to understand the intervention immediate effect. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05008081 -
The CATALINA Study
|
||
| Completed |
NCT06118684 -
Clinical Trial to Assess Effect of Verapamil on Systemic Exposure of EP395 and Effect of EP395 on Systemic Exposure of Midazolam and Digoxin
|
Phase 1 | |
| Recruiting |
NCT05808621 -
Muscle Oxygenation in Chronic Obstructive Pulmonary Disease
|
||
| Not yet recruiting |
NCT05769738 -
The Addition of Inhaled Furosemide to Standard Treatment of COPD Exacerbation
|
Phase 3 | |
| Recruiting |
NCT04816695 -
Volatolom Variation in Severe COPD During Hospitalization for Exacerbation and After Hospitalization (VOC-BPCO-Exa)
|
N/A | |
| Completed |
NCT05991778 -
Bioelectrical Impedance in Monitoring Hyperhydration and Polyneuromyopathy in Critically Ill Patients
|
||
| Completed |
NCT05079009 -
Effects of Blood Pulsatility on Von Willebrand Factor During ECCO2R
|
N/A | |
| Not yet recruiting |
NCT06105814 -
Improved Diagnostics, Treatment and Follow-up of Acute Exacerbation of Chronic Obstructive Pulmonary Disease
|
N/A | |
| Completed |
NCT05699720 -
Acute Exacerbation of COPD and Nebulized Magnesium Sulphate
|
N/A | |
| Recruiting |
NCT04223050 -
Comparing Mortality for Low vs High Peripheral Oxygen Saturation in COPD-patients With Acute Exacerbation
|
Phase 4 | |
| Completed |
NCT05776654 -
Wearable Devices in the Recovery Phase of Acute Exacerbations of COPD (AECOPDs)
|
||
| Completed |
NCT05691387 -
Comparison of Active Cycle of Breathing Technique and Pursed Lip Breathing With TheraPep
|
N/A | |
| Completed |
NCT04769505 -
Mindfulness-based Interventions in COPD Patients
|
N/A |